Home Healthcare Pharmaceuticals Anti-Fungal Treatment Market

Anti-Fungal Treatment Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Pyrimidines), By Therapeutic Indication (Systemic, Candidiasis, Cryptococcosis, Prophylactic Use of Antifungals, Coccidioidomycosis), By Pathogens (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton), By End-Users (Hospitals and Clinics, Dermatology Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
  7. North America Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
  8. Europe Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    8. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
  9. APAC Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
    6. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    9. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
  10. Middle East and Africa Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
  11. LATAM Anti-Fungal Treatment Market Size Analysis
    1. Introduction
    2. Anti-Fungal Treatment Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Pyrimidines
    3. Anti-Fungal Treatment Market Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
      1. Systemic
      2. Candidiasis
      3. Cryptococcosis
      4. Prophylactic Use of Antifungals
      5. Coccidioidomycosis
    4. Anti-Fungal Treatment Market Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
    5. Anti-Fungal Treatment Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals and Clinics
      2. Dermatology Clinics
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Pyrimidines
      3. Market Size & Forecast By Therapeutic Indication 2022-2034 (USD MILLION/ Units)
        1. Systemic
        2. Candidiasis
        3. Cryptococcosis
        4. Prophylactic Use of Antifungals
        5. Coccidioidomycosis
      4. Market Size & Forecast By Pathogens 2022-2034 (USD MILLION/ Units)
        1. Candida
        2. Aspergillus
        3. Cryptococcus
        4. Coccidioides Immitis
        5. Zygomycetes
        6. Trichophyton
      5. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals and Clinics
        2. Dermatology Clinics
  12. Competitive Landscape
    1. Anti-Fungal Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Astellas Pharma Ltd
    3. Novartis International Ag
    4. Sanofi S.A
    5. Merck KGaA
    6. Bayer Ag
    7. Abbott Laboratories
    8. Janssen Pharmaceuticals
    9. Gilead Sciences, Inc
    10. Cipla Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.